wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35934963-A74D8A59-0133-40E8-B1F0-FE48AE1A2395
Q35934963-A74D8A59-0133-40E8-B1F0-FE48AE1A2395
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35934963-A74D8A59-0133-40E8-B1F0-FE48AE1A2395
A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study.
P2860
Q35934963-A74D8A59-0133-40E8-B1F0-FE48AE1A2395
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35934963-A74D8A59-0133-40E8-B1F0-FE48AE1A2395
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
71576f6df05c336c6e22b2a2b53eef23ee3fd395
P2860
Identification of predictive markers of response to the MEK1/2 inhibitor selumetinib (AZD6244) in K-ras-mutated colorectal cancer.